Molecular Target Synopsis
Overview
Domains and Structures
Drugs and Clinical Candidates
Druggability
Chemistry
Ligand Efficiency Plot
Pathways
Family Cladogram
Interaction Network
Gene Expression
Gene Copy Number Variation
RNAi
Mutations
Germline Genetics

doxB (P0A111) - Domains And Structures - Molecular Target Synopsis

Click Here to View Molecular Target 3D Synopsis

Select a homology cutoff:
Structural Sequence Similarity Matches
Domains Covered Gene Name (Uniprot) Solved in Complex with Organism PDB Chain Identity E-Value Resolution Ligands Release Date
Rieske [2Fe-2S] domain (100%), Ring hydroxylating alpha subunit (catalytic domain) (100%) (view alignment) doxB (P0A111) doxD (P0A113) 2HMO_A 100 0 1.6Å 3NT 2006-10-10
Rieske [2Fe-2S] domain (100%), Ring hydroxylating alpha subunit (catalytic domain) (100%) (view alignment) doxB (P0A111) doxD (P0A113) 2HMK_A 100 0 1.65Å PEY 2006-10-10
Rieske [2Fe-2S] domain (100%), Ring hydroxylating alpha subunit (catalytic domain) (100%) (view alignment) doxB (P0A111) doxD (P0A113) 4HM2_A 100 0 1.26Å 16M 2013-10-30
Rieske [2Fe-2S] domain (100%), Ring hydroxylating alpha subunit (catalytic domain) (100%) (view alignment) doxB (P0A111) doxD (P0A113) 4HM5_A 100 0 1.5Å 16N 2013-10-30
Rieske [2Fe-2S] domain (100%), Ring hydroxylating alpha subunit (catalytic domain) (100%) (view alignment) doxB (P0A111) doxD (P0A113) 2HMM_A 100 0 1.6Å AN3 2006-10-10
Rieske [2Fe-2S] domain (100%), Ring hydroxylating alpha subunit (catalytic domain) (100%) (view alignment) doxB (P0A111) doxD (P0A113) 4HM1_A 100 0 1.5Å 1ON 2013-10-30
Rieske [2Fe-2S] domain (100%), Ring hydroxylating alpha subunit (catalytic domain) (100%) (view alignment) doxB (P0A111) doxD (P0A113) 4HM8_A 100 0 1.3Å 16R 2013-10-30
Rieske [2Fe-2S] domain (100%), Ring hydroxylating alpha subunit (catalytic domain) (100%) (view alignment) doxB (P0A111) doxD (P0A113) 4HKV_A 100 0 1.65Å UNU 2013-10-30
Rieske [2Fe-2S] domain (100%), Ring hydroxylating alpha subunit (catalytic domain) (100%) (view alignment) doxB (P0A111) doxD (P0A113) 4HM7_A 100 0 1.5Å SYN 2013-10-30
Rieske [2Fe-2S] domain (100%), Ring hydroxylating alpha subunit (catalytic domain) (100%) (view alignment) doxB (P0A111) doxD (P0A113) 4HM6_A 100 0 1.5Å 16Q 2013-10-30
Rieske [2Fe-2S] domain (100%), Ring hydroxylating alpha subunit (catalytic domain) (100%) (view alignment) doxB (P0A111) doxD (P0A113) 4HM4_A 100 0 1.5Å 16N 2013-10-30
Rieske [2Fe-2S] domain (100%), Ring hydroxylating alpha subunit (catalytic domain) (100%) (view alignment) doxB (P0A111) doxD (P0A113) 4HM0_A 100 0 1.8Å IAC 2013-10-30
Rieske [2Fe-2S] domain (100%), Ring hydroxylating alpha subunit (catalytic domain) (100%) (view alignment) doxB (P0A111) doxD (P0A113) 2HML_A 100 0 1.8Å PEY 2006-10-10
Rieske [2Fe-2S] domain (100%), Ring hydroxylating alpha subunit (catalytic domain) (100%) (view alignment) doxB (P0A111) doxD (P0A113) 2HMJ_A 100 0 1.5Å - 2006-10-10
Rieske [2Fe-2S] domain (100%), Ring hydroxylating alpha subunit (catalytic domain) (100%) (view alignment) doxB (P0A111) doxD (P0A113) 4HM3_A 100 0 1.5Å PYJ 2013-10-30
Rieske [2Fe-2S] domain (100%), Ring hydroxylating alpha subunit (catalytic domain) (100%) (view alignment) doxB (P0A111) doxD (P0A113) 2HMN_A 100 0 1.7Å AN3 2006-10-10
Rieske [2Fe-2S] domain (100%), Ring hydroxylating alpha subunit (catalytic domain) (100%) (view alignment) doxB (P0A111) doxD (P0A113) 4HJL_A 100 0 1.5Å 15O 2013-10-16